Why the study?
How do dermasurgeons manage perioperative anticoagulant and antiplatelet therapy during cutaneous surgery?
Population
720 dermasurgeons (Mohs surgeons) surveyed, with a 38% response rate
Comparison
Survey on perioperative management of… vs Results from a similar survey in 2002
Design
Cross-sectional
Authors
Loading...
Survey data update 2002 practices without guiding decisions; leaves optimal perioperative strategies open for prospective study.
How do dermasurgeons manage perioperative anticoagulant and antiplatelet therapy during cutaneous surgery?
Dermasurgeons in 2005 were more likely to continue medically necessary aspirin and warfarin compared to 2002, though significant variation in practice remains.
Kirkorian et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: